Education
About Us
Working with TipRanks
Follow Us
Matthew W. Foehr Insider Profile
4 Followers
Matthew W. Foehr, Former Executive Officer at Ligand Pharma, holds 3.78M shares in OmniAb (Ticker: OABI), holds 162.19K shares in Ligand Pharma (Ticker: LGND), holds 0.00 shares in OmniAb, Inc. (Ticker: OABIV).
Matthew W. Foehr Ligand Pharma (LGND)Former Executive Officer
Ligand Pharma (LGND)
Former Executive Officer
Ranked #1,823 out of 100,956 Corporate Insiders
Profitable Transactions
16 out of 32 Profitable Transactions
Average Return
+26.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew W. Foehr holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 03, 2022 - May 03, 2023
Return:+754.50%
The most profitable trade made by Matthew W. Foehr
Matthew W. Foehr's Trading History
Ligand Pharma
Nov 03, 2022
Former Executive Officer
Uninformative Sell
―
$18.62M
OmniAb
Feb 19, 2025
President & CEO, Director
Uninformative Buy
112.48K
$12.85M
OmniAb, Inc.
Nov 03, 2022
―
Uninformative Sell
―
$0.00
Viking Therapeutics
May 03, 2022
Director
Informative Buy
111.15K
$3.24M
Qualigen Therapeutics
Apr 23, 2020
Director
Uninformative Buy
100.00K
$432.54K
List of latest transactions for each holding click on a transaction to see Matthew W. Foehr's performance on stock
You May Also Like
Matthew W. Foehr insider profile FAQ
What is the percentage of profitable transactions made by Matthew W. Foehr?
The percentage of profitable transactions made by Matthew W. Foehr is 50%.
What is the average return per transaction made by Matthew W. Foehr?
The average return per transaction made by Matthew W. Foehr is 26.90%.
What stocks does Matthew W. Foehr hold?
Matthew W. Foehr holds: LGND, OABI, OABIV, VKTX, QLGN stocks.
What was Matthew W. Foehr’s latest transaction?
Matthew W. Foehr latest transaction was an Uninformative Buy of $112.48K.
What was Matthew W. Foehr's most profitable transaction?
Matthew W. Foehr’s most profitable transaction was an Informative Buy of VKTX stock on May 3, 2022. The return on the trade was 754.50%.
What is Matthew W. Foehr's role in Ligand Pharma?
Matthew W. Foehr's role in Ligand Pharma is Former Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.